CTS: 3 Key Takeaways for Long-Term Investors
On its third-quarter 2026 earnings call, held on Oct. 27, 2026, CTS(NYSE:CTS) raised its full-year sales guidance to between $580 million and $590 million. The component manufacturer is shifting its revenue base toward higher-margin medical and industrial markets while light vehicle production slows.
Three takeaways from management show how this business model transition is progressing.
1. The Millar Acquisition Expands High-Margin Medical Reach
Management completed the acquisition of Millar for $50 million in cash, adding $30 million in annual medical sensor revenue. The deal accelerates the company's strategic push into healthcare applications, where medical segment sales grew 21% year over year to $27 million.
The recently completed acquisition of Millar represents another important step in our strategy to reshape CTS toward a more diversified portfolio of high-value, differentiated technologies serving attractive end markets.
-- Pratik Trivedi, Chief Executive Officer
2. Mix Timing Boosted Third-Quarter Gross Margins
Gross margin, the percentage of revenue remaining after direct manufacturing costs, expanded 3.3 percentage points year over year to a record 42.2% on favorable project timing and operational execution. Management expects gross margin to normalize in upcoming quarters as project schedules balance out.
The year-over-year improvement was driven by operational execution, a favorable impact of approximately $1.4 million from foreign currency changes, and an above normal favorable impact of end market mix driven by timing of certain projects.
-- Ashish Agrawal, Vice President and Chief Financial Officer
3. Defense Backlog Provides Support Against Auto Flatness
While transportation sales rose just 2% year over year as light-vehicle production stalled, demand for military and defense products expanded. The defense segment generated a 1.91 book-to-bill ratio, meaning incoming customer orders exceeded current shipments by 91%.
Orders remained very healthy, as reflected in our 1.91 book-to-bill ratio, providing strong support for future growth.
-- Pratik Trivedi, Chief Executive Officer
Looking Ahead
Full-year sales targets are rising as medical and defense demand offsets flat light vehicle production. CTS relies on microfabrication capabilities and defense contract wins while watching auto platform timing and tariff shifts.
Assuming the continuation of current market conditions for the full year 2026, we are raising our guidance with sales now expected in the range of $580 million-$590 million, and adjusted diluted EPS in the range of $2.78-$2.88.
-- Pratik Trivedi, Chief Executive Officer
Long-term expansion depends on operational discipline across newly acquired platforms.
The CTS Business System provides the foundation for how we execute these priorities with a focus on growth, operational rigor, employee engagement, and supporting our communities.
-- Pratik Trivedi, Chief Executive Officer
Should you buy stock in CTS right now?
Before you buy stock in CTS, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and CTS wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflixmade this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $341,966!* Or when Nvidiamade this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,146,819!*
Now, it's worth noting Stock Advisor's total average return is 852% — a market-crushing outperformance compared to 203% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor , and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of November 7, 2026.
The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy .
CTS: 3 Key Takeaways for Long-Term Investors was originally published by The Motley Fool
